Skip To Main Content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

Atherothrombosis

Discover more on science updates, events, KOLs interviews and more on Atherothrombosis

Science in Atherothrombosis

Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

No Rebound Effect Post Clopidogrel Withdrawal

No Rebound Effect Post Clopidogrel Withdrawal

Insights and impacts from the TALOS-AMI Trial

Insights and impacts from the TALOS-AMI Trial

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

De-escalation to Clopidogrel in AMI

De-escalation to Clopidogrel in AMI

Clopidogrel vs aspirin post PCI following DAPT

Clopidogrel vs aspirin post PCI following DAPT

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

P2Y12 inhibitors after Coronary stenting

P2Y12 inhibitors after Coronary stenting

Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI

Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources

No Rebound Effect Post Clopidogrel Withdrawal

No Rebound Effect Post Clopidogrel Withdrawal

Insights and impacts from the TALOS-AMI Trial

Insights and impacts from the TALOS-AMI Trial

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

De-escalation to Clopidogrel in AMI

De-escalation to Clopidogrel in AMI

Clopidogrel vs aspirin post PCI following DAPT

Clopidogrel vs aspirin post PCI following DAPT

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

P2Y12 inhibitors after Coronary stenting

P2Y12 inhibitors after Coronary stenting

Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI

Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI